Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guselkumab in Chinese Adults With Moderate to Severe Plaque Psoriasis
CTR20211352Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of guselkumab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started Jun 2021; status: completed.
02
Drugs
guselkumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20211352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211352.